Form Filed By Hakim Nasrat A
Fri, Feb 7, 2014
Go to original document
ELITE PHARMACEUTICALS INC /NV/ (ELTP)
Healthcare
Drug Manufacturers—Specialty & Generic
Insights
Coming soon
Non Derivative Transactions
2014-02-07
Series I Convertible Preferred Shares
Derivative Conversion
C
Type
Acquired 100 shares @ $100,000.00 per share
100 shares
By Mikah Pharma, LLC
Indirect
Footnotes
1. Principle amount of convertible note.
2. These preferred shares are convertible into shares of common stock at the rate of 1,428,571.43 shares common stock for each whole shares of preferred stock.